Immunisation Community of Practice

Shield yourself from shingles - Resources collection

This collection contains fact sheets, brochures, posters and a health professionals' kit about shingles vaccinations for eligible people.

Please use the link below for recipes to find people who are eligible for the Shingles vaccination

PenCS Shingles

A 2-dose course of Shingrix® is available on the NIP for:

• people aged 65 years and older
• First Nations people aged 50 years and older
• immunocompromised people aged 18 years and older with the following medical conditions:
  • haemopoietic stem cell transplant
  • solid organ transplant
  • haematological malignancy
  • advanced or untreated HIV

NSW Immunisation Schedule

The updated NSW Immunisation Schedule and FAQs are now live on the immunisation webpage.

Subscribe to stay up to date with the latest clinical and program guidance on the National Immunisation Program (NIP) to help you deliver immunisation services to your patients.

About the NIP updates

The updates provide the latest information to assist providers administer vaccines on the NIP, including:

• changes to the NIP schedule

• clinical advice, including ATAGI clinical statements

• annual influenza program communication

• Australian Immunisation Register information.

We publish influenza program updates annually, and as needed for other NIP updates.

Who they are for

Our updates are for health professionals who have a role in promoting and administering NIP funded vaccines, including:

• general practitioners

• nurses

• midwives

• Aboriginal and Torres Strait Islander health practitioners and workers

• specialists

• pharmacists

• practice managers and administrators.

How to subscribe

To receive NIP updates by email simply complete our online subscribe form.

Subscribe to NIP updates

After completing the form, you will receive an email requesting confirmation. Click on the link in the email to confirm your subscription.

How to unsubscribe

If you no longer want to receive the NIP updates, you can unsubscribe using the link at the bottom of each email.

How to access old updates

Find previous updates in the NIP updates archive.

Privacy

See the privacy notice for this service.

From 1 November 2023, Shingrix® will replace Zostavax® on the National Immunisation Program and will be funded for everyone aged 65 years and over, First Nations people 50 years and over, and immunocompromised people 18 years and over at high risk of herpes zoster infection.

¹ National Immunisation Program - changes to shingles vaccination from 1 November 2023 | Australian Government Department of Health and Aged Care

Following a recent increase in enquires regarding Zostavax availability, the NSW Immunisation Unit have managed to secure a small additional supply of vaccine that allows an increase ordering volumes for eligible providers to support any additional demands following the pending inclusion of Shingrix to the NIP.

Following feedback from the Aged Care providers and NSW Public Health Units, NSW Health has streamlined the ordering process for Residential Aged Care Facilities to order the NSW Stockpile of Oseltamivir (Tamiflu) for Influenza treatment and prophylaxis.

NSW Health has a limited supply of Oseltamivir (Tamiflu) available for facilities that are unable to source their own access to Oseltamivir (Tamiflu) via their local General Practitioner.

Residential Aged Care Facilities are now able to order up to 250 courses of Oseltamivir (Tamiflu) via RACF influenza antiviral treatment access - Immunisation programs (nsw.gov.au) following consultation and prescription from a General Practitioner.

For orders over 250 courses please consult with your local public health unit.

The Australian Government Department of Health and Aged Care (DoHAC) has advised that their mandatory COVID-19 Vaccination Training Program (CVTP) will be ending on 1 October 2023. From 1 October 2023, clinicians participating in the administration of COVID-19 vaccines will no longer be required to complete the COVID-19 vaccine training modules developed by DoHAC in partnership with the Australian College of Nursing (ACN) and the learning platform will close.

The latest Provider Bulletin provides additional information on the cessation of the CVTP.

Authorised nurse and midwife immunisers and pharmacist immunisers that have undertaken the required training to supply and administer vaccines independent of a medical order will still be required to comply with NSW requirements. The Authority for registered nurses and midwives and the NSW Pharmacist Vaccination Standards have been revised and amended to include the following requirements for authorised immunisers administering COVID-19 vaccines:

• must have read the ATAGI guidance on the use of multi-dose vials for COVID-19 vaccinations;
• must have reviewed the NSW guidance on management of COVID-19 vaccines specific to each the vaccines that the immuniser will be administering (see NSW Health COVID-19 vaccination webpage for immunisation providers)

Additional information on immunisation is available on the NSW Health webpage.

NSW Health is urging the community to be on alert for symptoms of meningococcal disease and act immediately if they appear after the notification of recent cases.Meningococcal disease is a rare, but serious and sometimes fatal infection.

Meningococcal disease can cause lifelong damage – organ failure, disability, death.

15–25-year-olds are at higher risk.

Know the symptoms and see a doctor urgently.

Meningococcal symptoms include:

• sudden fever
• nausea and vomiting
• severe limb pain
• severe headache
• difficulty waking up
• stiff neck
• upset by bright lights
• high pitched crying in babies
• red-purple rash which doesn’t disappear when pressed with a glass

In-country technical assistance on immunisation in Solomon Islands